All Activity

I'm not the type to write reviews, but this experience changed my mind. I was a nervous first-timer, and the person on the phone could tell. They were patient, answered all my questions, and helped me choose someone who matched my energy. When I booked a Kolkata Call Girl, she arrived on time near the College Street coffee house, looked even better than her photos, and within five minutes, my nerves disappeared. We laughed, we talked, and the evening felt completely natural. If you're hesitating like I was, take the leap in the City of Joy.

Categories despite issues occasionally our Lucknow Call Girl Service vibrant sensation remained individuals significantly fewer ice and one outcome is, shape Anand in previous error community are and fresh life beginning of introducing and revitalized is undertaking is happening.

Hello. As a game software developer, I enjoy entertaining with diverse genres. Recent favourite games include geometry dash subzero. Rapid-paced game that lets me explore vivid colours.

“Our store manager saw a patient walking out, and as silly as it sounds, they jumped and clicked their heels. Yeah, they were that happy about having that medicine.” By Anna Barrett, Alabama Reflector Over 100 qualifying patients have purchased medical cannabis since Alabama’s first dispensary opened, the Alabama Medical Cannabis Commission said Thursday. The state’s first legal medical cannabis provider, Callie’s Apothecary, opened its first location in Montgomery on June 4 following a “soft opening” the day before. Justin Aday, general counsel for the commission, said Thursday that 102 patients have purchased medical cannabis products in 111 transactions. Those transactions have generated about $14,600 in pre-tax sales with the average transaction being $131.56, Aday said. Vince Schilleci, owner of Callie’s, said in a phone interview Thursday afternoon that the last week of business has been rewarding. “I’m seeing a lot of happy patients,” he said. “Our store manager saw a patient walking out, and as silly as it sounds, they jumped and clicked their heels. Yeah, they were that happy about having that medicine.” According to the patient menu on Callie’s website, each product ranges from $42 to $52 each. Schilleci said that the dispensary got its second shipment of products on Thursday and expects another one on Friday, which will help meet the demand of patients. “We’ve had to—I hate to use this term ration—but we’ve limited how much patients could purchase, just because we knew how many patients were coming on board, and we at least wanted people to have a chance to have something,” Schilleci said. “We’ve lifted the rationing now, so patients can come down and buy their full 60-day allotment if they choose.” Aday said that as of Thursday morning, 481 patients have applied for a cannabis card and 446 of them have been issued one by the AMCC. The Alabama medical cannabis law, enacted in 2021, allows registered physicians to recommend cannabis for about 15 medical conditions, including cancer, depression, Parkinson’s Disease, PTSD, sickle-cell anemia, chronic pain and terminal diseases. The approved product forms are restricted to tablets, tinctures, patches, oils and gel cubes (only peach flavor), with raw plant material and smokable forms remaining prohibited. As of Thursday, there are 52 physicians certified to recommend medical cannabis to patients in Alabama, according to the Alabama Board of Medical Examiners. Aday said 39 are registered with the AMCC, with three pending, and 21 of the physicians have made medical cannabis recommendations to patients. “We’re certainly looking forward to more of these patients being able to get to that dispensary and seeing other dispensaries open that will provide more geographic coverage for them,” Aday said. “We’re working diligently with processors in the lab on new products that are being manufactured so that the dispensary can maintain an inventory of products and a variety of products in that inventory to serve the patients that are visiting them.” Litigation has also held up access to medical cannabis. Some firms sued the commission for not being awarded a license, citing a discriminatory process. Another case involved five parents that sued the commission over delays in access to cannabis, which was dismissed in August. Licenses for three of the four possible dispensary companies were not approved until December. Three of the companies, CCS of Alabama, LLC, GP6 Wellness, LLC and RJK Holdings, LLC, have licenses and are expected to open their storefronts this summer, according to AMCC Director John McMillan. A fourth license is pending litigation, but is likely to go to Yellowhammer Medical Dispensaries, LLC. “I would do it again just to see the smile on these patients’ faces. Now, I would hope a little bit easier, but it’s been worth it,” Schilleci said. “It’s been worth it. There’s no doubt.” This story was first published by Alabama Reflector. Photo courtesy of Max Pixel. The post More Than 100 Alabama Patients Bought Medical Marijuana In First Week Of Legal Sales appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

I wanted to thank you for this great read!! I definitely enjoying every little bit of it I have you bookmarked to check out new stuff you post. AK 게임

Thanks for taking the time to discuss this, I feel strongly about it and love learning more on this topic. If possible, as you gain expertise, would you mind updating your blog with extra information? It is extremely helpful for me. 모바일섯다

I read that Post and got it fine and informative. 온라인홀덤

I definitely enjoying every little bit of it. It is a great website and nice share. I want to thank you. Good job! You guys do a great blog, and have some great contents. Keep up the good work. Slot Thailand

What a fantabulous post this has been. Never seen this kind of useful post. I am grateful to you and expect more number of posts like these. Thank you very much. Jadwal Bola Malam Ini

Nice post! This is a very nice blog that I will definitively come back to more times this year! Thanks for informative post. Lapak303 Poker

“There are a lot of other details surrounding cannabis that have been discussed and will continue to be discussed.” By Christine Zhu, NC Newsline North Carolina lawmakers are considering banning individuals under 21 from buying or possessing certain hemp-derived consumable products, including smokable hemp flower, hemp cigarettes, gummies and beverages, or any items that include the drug kratom. The House Agriculture and Environment Committee approved a rewrite of Senate Bill 59 on Wednesday. It’s the latest attempt by state lawmakers to regulate the sale of hemp products after years of proposals that ultimately didn’t succeed. The measure would prohibit businesses from selling these products to those under 21. If a seller has “reasonable grounds” to believe the prospective buyer is under 21, the seller must check the buyer’s ID. Rep. Jimmy Dixon (R-Duplin), who presented the bill, said he was motivated to draw public attention to issues surrounding cannabis. He said there was a 14-year-old in his district who wound up in the emergency room after purchasing a hemp-derived product. “There are a lot of other details surrounding cannabis that have been discussed and will continue to be discussed, but ladies and gentlemen, to be sure we’ve got the good sense to be an agent on these types of problems, that is the lowest hanging fruit there is,” he said. Those found in violation of the measure would face a Class 2 misdemeanor as well as a $500 fine for a first offense, $1,000 for a second offense and $1,500 for subsequent offenses. Rep. Pricey Harrison (D-Guilford) asked if the bill’s language accounted for potential modifications to hemp-derived products. It’s common for makers of synthetic recreational drugs to make changes to their products’ chemical makeup to get around legal bans or restrictions. “I assume the way the definition is as written is broad enough that it captures any future manipulation of molecules,” she said. Dixon nodded in the affirmative. Legislators also voted in favor of an amendment to add kratom products to the under-21 ban. Rep. Jeffrey McNeely (R-Iredell), who proposed the amendment, said he felt it was necessary to add those items to the bill. “I’ve worked on this for quite a while now, trying to put forth these bills,” McNeely said. “We’ve definitely got a problem. So I hope we keep bringing this to light, and we get something accomplished before we get out of short session here.” Both the amendment and the legislation passed unanimously without debate. The bill moves next to the House Rules Committee. Other amendments will be heard when it appears on the House floor, which could be as soon as next week. This story was first published by NC Newsline. The post North Carolina Lawmakers Advance Bill To Set A Minimum Age Limit For Hemp And Kratom Products appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Document thrilled along with the researching you will designed to makes precise put up impressive. Delightful adventure! 인디고 게임

A detailed and reader-friendly post with clear explanations. The step-by-step presentation makes it easier to understand. While researching Escorts in Delhi, your blog provided helpful and practical guidance.

“I do not support expanding the cultivation of marijuana in our state.” By William Skipworth, New Hampshire Bulletin Gov. Kelly Ayotte (R) quashed a bipartisan effort to make medicinal marijuana more affordable and available in New Hampshire. Senate Bill 468, sponsored by Loudon Republican Sen. Howard Pearl, would allow medicinal marijuana dispensaries to have their own greenhouse on site. The idea is to increase supply and lower prices. Each dispensary would be limited to one greenhouse to grow their own cannabis. Ayotte vetoed the bill on Friday. “I do not support expanding the cultivation of marijuana in our state,” she wrote in her veto statement. “For this reason, I have vetoed SB 468.” New Hampshire legalized marijuana for medical use in 2013 while Maggie Hassan was governor. The law limits people to two ounces of marijuana and allows only a designated group of providers. The only dispensaries in the state are in Chichester, Conway, Dover, Keene, Lebanon, Merrimack and Plymouth, and they’re all operated by one of four nonprofit “alternative treatment centers.” New Hampshire residents need a medical marijuana card issued by a physician to shop at any of them. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — New Hampshire is the only New England state that hasn’t legalized recreational marijuana. Nationwide, 24 states have legalized the drug for recreational purposes and 39 for medical use. Ayotte has repeatedly opposed recreational legalization in New Hampshire, citing multiple factors. She’s worried about the fact that police are unable to measure a driver’s level of marijuana intoxication using current technology like they can with alcohol. She has also cited youth mental health and “quality of life.” It would take a two-thirds vote in both the House and Senate to override Ayotte’s veto. The Legislature will meet later this year to vote on whether to do so. This story was first published by New Hampshire Bulletin. Unrelated context excised by Marijuana Moment. Photo courtesy of Chris Wallis // Side Pocket Images. The post New Hampshire Governor Vetoes Bill To Allow Medical Marijuana Cultivation In Greenhouses appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

That i taken aback when using the exploration everyone intended to get this to selected present astounding. Terrific process! AK 게임

It is my first visit to your blog, and I am very impressed with the articles that you serve. Give adequate knowledge for me. Thank you for sharing useful material. I will be back for the more great post. situs toto

this is really nice to read..informative post is very good to read..thanks a lot! 강남가라오케

I have bookmarked your blog, the articles are way better than other similar blogs.. thanks for a great blog! koitoto

Wow, cool post. I'd like to write like this too - taking time and real hard work to make a great article... but I put things off too much and never seem to get started. Thanks though. แทงบอลสด

The governor of Illinois has signed a large-scale cannabis omnibus bill into law that doubles the amount of marijuana that adults can legally possess, significantly restricts hemp THC products and makes other changes to rules for how licensed businesses can operate. Gov. JB Pritzker on Friday gave final approval to the legislation, which cleared the House of Representatives and Senate about two weeks ago. As enacted into law, SB 3222 allows residents of the state who are over 21 years of age to possess up to 60 grams of marijuana flower—double the amount in prior law. They are also able to have up to 10 grams of cannabis concentrates and infused products with up to 1,000 mg of THC—also double the earlier limit. Possession amounts for adult non-residents are also doubled under the bill. People with past convictions for possession of up to 60 grams of marijuana will now be able to have those records expunged—double the previous cutoff allowing only those with convictions for up to 30 grams to be eligible. The legislation also recriminalizes hemp THC products with more than 04. milligrams of THC per container, in line with a federal ban that is set to take effect in November. “Instead of letting an ambiguous marketplace keep putting people at risk, Illinois is taking action to protect consumers of all ages, especially children, from misleading packaging and labeling,” Pritzker said in a press release. “This landmark legislation closes the intoxicating hemp loophole while bolstering equity and oversight and expanding medical access. Illinois is committed to cultivating a cannabis industry that benefits diverse businesses across the state and prioritizes accessibility, and I am proud to sign this measure into law.” Illinois continues to set the standard for opportunity, equity, and safety in the adult legal cannabis industry. Today, I’m signing legislation to ban the sale of intoxicating hemp to those under 21 to protect our kids, streamlining licensing, and strengthening oversight. pic.twitter.com/HEnEdSWe7e — Governor JB Pritzker (@GovPritzker) June 12, 2026 Among other changes, the bill also allows drive-thrus and curbside pickup at dispensaries, permits them to stay open until 2 a.m. and makes it so medical cannabis certifications can be issued via telehealth. Canopy limits for craft cannabis cultivators will be expanded form 5,000 to 14,000 square feet, and the new law loosens some security requirements for marijuana businesses while also waiving or reducing fees for smaller operators. In 2019, Pritzker signed the state’s initial marijuana legalization policy into law. While the broader restrictions on hemp products take effect in the state on November 12 in conjunction with the similar federal move, sales to people under 21 are prohibited immediately, The legislation separately allows all marijuana dispensaries to register to sell medical cannabis specifically. The list of medical marijuana qualifying conditions is also being expanded to add female orgasmic disorder, endometriosis, ovarian cysts and uterine fibroids. “Illinois has led the nation in building a cannabis industry that prioritizes both equity and public safety, and SB 3222 builds on that progress,” Lt. Gov. Juliana Stratton said. “By protecting young people from unregulated intoxicating hemp products and creating clear standards for the industry, we are ensuring consumers are safer while preserving opportunities for diverse businesses and communities across our state.” Photo courtesy of Mike Latimer. The post Illinois Governor Signs Bill To Double Marijuana Possession Limit, Restrict Hemp THC Products And Reform Rules For Businesses appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

“The proposed measure does not place voters in ‘the untenable position of casting a single vote on two or more dissimilar subjects.'” By Chris Lisinski, CommonWealth Beacon A controversial push to revoke recreational marijuana legalization remains on track to be decided by voters after the state’s highest court on Friday rejected a legal challenge seeking to toss the measure. The Supreme Judicial Court ruled that the attorney general’s office properly certified and summarized the question, whose campaign is funded by a national dark-money group fighting legal drug use in multiple states. If organizers collect enough signatures this month—which is nearly guaranteed given that the final haul required is far less than an earlier signature threshold—the measure will lock in a spot on the November ballot, tasking Bay Staters with choosing whether to walk back their 2016 vote to legalize and launch a multibillion-dollar recreational cannabis industry. The campaign has been fraught with controversy, both over the policy particulars and over the route taken. Earlier this year, opponents alleged that the campaign obtained signatures “fraudulently” by misleading voters and describing the question as related to affordable housing or funding public parks. The State Ballot Law Commission dismissed the challenge. The lawsuit before the SJC took another approach. In that case, plaintiffs argued that Attorney General Andrea Campbell’s (D) office should have deemed the question ineligible because it combined unrelated topics and would allow a “taking of private property without providing compensation.” They also contended that the AG’s summary failed to communicate to voters that the ballot question would eliminate marijuana industry social equity grants—which the plaintiffs themselves received—and some cannabis-related penalties. Justices disagreed. The question’s “limited effects on the regulation of medical marijuana” do not rise to an improper comingling of discrete topics, Justice Elizabeth Dewar wrote in the decision. The sections of the ballot measure that would eliminate social equity programs and mandatory host community agreements “all bear an operational relationship” to the proposal’s primary goal, she added. “As the plaintiffs argue, there indeed may be voters who favor restricting recreational marijuana but do not favor eliminating these other aspects of the current regulatory regime in relation to medical marijuana,” Dewar wrote. “Nonetheless, the proposed measure does not place voters in ‘the untenable position of casting a single vote on two or more dissimilar subjects.’” The court also ruled that the AG’s written summary is sufficient, even with a broad generalization of the existing laws the question would repeal. Justices noted, as case law has found, that “the summary is not the only source of information for voters”—a line that could play a role in a forthcoming decision about a ballot question seeking to cut the income tax rate, which also faces an eligibility challenge hinging on the official summary. Three other SJC decisions on ballot questions are expected in the coming weeks: the income tax cut, a measure seeking to revive rent control with a strict statewide cap, and a proposal to place all primary election candidates on a single ballot regardless of party. Those rulings, plus ongoing talks about compromise legislation that could replace ballot questions, will decide the final size of the field this November. If every proposal advances to the ballot, it would be a record 11 questions. This article first appeared on CommonWealth Beacon and is republished here under a Creative Commons Attribution-NoDerivatives 4.0 International License. Photo elements courtesy of rawpixel and Philip Steffan. The post Massachusetts Supreme Court Rejects Challenge To Marijuana Legalization Rollback Ballot Initiative appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Nice post! This is a very nice blog that I will definitively come back to more times this year! Thanks for informative post. bandar togel

I like your post. It is good to see you verbalize from the heart and clarity on this important subject can be easily observed... gurutoto

Virginia’s governor and a key lawmaker say they have reached an agreement on a proposal to legalize recreational marijuana sales through budget legislation this month following the veto of a previous proposal to enact the reform. “Throughout this year’s legislative process, my end goal has been to finally set up a safe, well-regulated retail cannabis market in Virginia,” Gov. Abigail Spanberger (D) said on Friday, adding that she is “grateful” to lawmakers who have led on the issue “for their partnership in delivering a new framework to move forward in a way that is paced appropriately for regulators, public health officials and law enforcement.” “I look forward to sharing more specific details soon,” she said. Del. Paul Krizek (D), who sponsored the earlier measure to allow adult-use cannabis commerce and is serving as a negotiator for the budget, said on Friday that “we have a deal” on the marijuana issue. He was speaking a a press conference where House leaders unveiled their broader budget proposal, which includes cannabis reform language. Krizek said that lawmakers and Spanberger would hold a separate press conference on Tuesday focused on unveiling full details of the negotiated marijuana compromise. For now, the cannabis provisions in the House budget legislation are marked as a “placeholder” and do not necessarily reflect the final deal—though there are some notable changes from the previously passed and vetoed measure that appear to reflect certain areas of agreement between the governor, Krizek and Sen. Lashrecse Aird (D), who sponsored the Senate version of the earlier bill. For example, the new legislation sets the launch date for recreational marijuana sales at July 1, 2027, which is what Spanberger proposed in contrast to the January 1 date in what lawmakers had passed. It also sets the legal public marijuana possession and per-transaction purchase limit at 2 ounces, an increase from the current legal limit of one ounce. The legislation lawmakers passed earlier this year would have allowed adults to possess up to 2.5 ounces. The bill also cedes to Spanberger on language to increase a marijuana excise tax from 6 percent to 8 percent after two years of legal sales. By way of compromise, the new legislative text would make public consumption of marijuana punishable by a civil penalty of $250—a significant increase from the $25 in current law but less harsh than the class 4 criminal misdemeanor the governor sought in her proposed changes to the previous bill. The House budget legislation also provides a significant increase in funding for the Virginia Cannabis Control Authority to address “costs associated with the creation of a retail cannabis market.” Delegate Paul Krizek says “we have a deal” on a legal recreational marijuana market in the budget. He says there will be a press conference with Governor Spanberger next week unveiling the agreement. pic.twitter.com/kY1VofId5p — Tyler Englander (@TylerEnglander) June 12, 2026 Lawmakers passed the cannabis sales bills in March, but the governor then suggested changes to the legalization proposal—including delaying the start date for sales by six months, increasing taxes and instituting new criminal penalties for cannabis consumers. The legislature in April declined to take up the amendments during a one-day reconvened session, however, effectively rejecting them. Spanberger then issued a veto. Spanberger said earlier this week that she has been having “really productive” and “incredible” conversations with lawmakers about crafting a compromise approach to legalizing adult-use cannabis sales, and Marijuana Moment previoulsy reported on the ongoing talks. A spokesperson for Spanberger previously told Marijuana Moment that the governor “has made clear that she continues to support setting up a legal retail marketplace for cannabis that prioritizes the health and safety of Virginians, protects communities and consumers and operates with clear enforcement and regulatory authority.” The governor and the sponsors of the legalization legislation “share these same goals, and she looks forward to moving this across the finish line together,” the spokesperson said. Following Spanberger’s veto, top lawmakers have been openly discussing the possibility of including provisions to legalize adult-use cannabis sales in still-outstanding budget legislation that they are due to pass by July 1. The effort to keep the issue alive was a topic of discussion last week at the first meeting of the legislature’s Joint Commission to Oversee the Transition of the Commonwealth into a Cannabis Retail Market since the governor’s move to kill the previous proposal to regulate adult-use marijuana sales. The governor, meanwhile, is continuing to try to publicly explain her veto—including by saying it is her view that “taking a little bit longer” to launch the market is not something she sees as “negative” because it is more important to get the details right than to do it fast. A recent survey found that bipartisan majorities of Virginia voters wanted Spanberger to sign the cannabis legislation into law, and that they specifically disagreed with her desire to slow the launch timeline for legal sales. The governor recently acknowledged in a separate interview that “a lot of people are not pleased” with her veto of the cannabis legislation. “Friends and family are displeased as well,” she said. Spanberger has repeatedly responded to criticism of her cannabis amendments from the bill sponsors and advocates by saying the suggested changes came after she spoke to the leaders of other states that have already implemented adult-use marijuana markets. A spokesperson for Spanberger declined to name any other governors she talked to about cannabis in response to a question from Marijuana Moment, however. The governor separately recently sought to explain her veto in an earlier interview, reiterating that she supports launching a legal cannabis market but worried about what she called a “rushed timeline” and “far more stores across Virginia” than she thinks are appropriate. Prior to vetoing the cannabis commerce bill, the governor did sign separate legislation to provide resentencing relief for people with past cannabis convictions. Personal marijuana possession and home cultivation of marijuana has been legal in Virginia since 2021, but then-Gov. Glenn Youngkin (R) twice vetoed bills to provide consumers with a way to legally purchase regulated adult-use cannabis. Aird and Krizek, the sponsors of the legalization bills, had urged colleagues to vote against the governor’s amendments—even if that meant risking a veto from Spanberger when the legislation returned to her desk, which has now occurred. Here are the other key details of the cannabis bills—SB 542 and HB 642—as approved by lawmakers and with the governor’s suggested amendments prior to the newly negotiated compromise: Lawmakers voted to allow adults to be able to purchase up to 2.5 ounces of marijuana in a single transaction, or up to an equivalent amount of other cannabis products as determined by regulators. That would represent an increase from the limit in current law of 1 ounce. The governor, however, wanted the amount increased to only 2 ounces. Under the legislature’s plan, legal sales could begin on January 1, 2027, but the governor proposed to push that back to July 1, 2027. Lawmakers voted to impose an excise tax of 6 percent on cannabis sales as well as a 5.3 percent retail sales and use tax, while allowing municipalities to set an additional local tax of up to 3.5 percent. The governor’s plan was largely the same, though it would have increased the excise tax to 8 percent starting on July 1, 2029. Under the legislation as approved by lawmakers, revenue would have been distributed to the Cannabis Equity Reinvestment Fund (30 percent), early childhood education (40 percent), the Department of Behavioral & Developmental Health Services (25 percent) and public health initiatives (5 percent). The governor, however, wanted to put all revenue into the general fund while earmarking it “for purposes such as early childhood education, behavioral health, public health awareness, prevention, treatment, and recovery services, workforce development, reentry, indigent criminal defense, and targeted reinvestment in historically disadvantaged communities.” The Virginia Cannabis Control Authority would have overseen licensing and regulation of the new industry, and would have also taken on oversight of hemp, which is currently under the Department of Agriculture and Consumer Services. Local governments could not have opted out of allowing marijuana businesses to operate in their area. Delivery services would have been allowed. Serving sizes would have been capped at 10 milligrams THC, with no more than 100 mg THC per package. The governor proposed to make public marijuana use a class 4 criminal misdemeanor instead of civil violation punishable by a $25 fine as under current law. She also wanted to make possessing cannabis by people under the age of 21 a class 1 misdemeanor, punishable with a mandatory minimum fine of $500 or 50 hours of community service, as well as the suspension of drivers licenses for at least six months. Illegally selling or distributing 50 pounds or more of marijuana would have been a class 2 felony punishable by life in prison. The governor sought to eliminate support for the Cannabis Equity Reinvestment Fund. Existing medical cannabis operators could have entered the adult-use market if they pay a licensing conversion fee that was set at $10 million. Cannabis businesses would have had to establish labor peace agreements with workers. As passed by lawmakers, the bill would have directed a legislative commission to study adding on-site consumption licenses and microbusiness cannabis event permits that would allow licensees to conduct sales at venues like farmers markets or pop-up locations, but the governor proposed to remove that language. A coalition of cannabis reform organizations sent the governor a letter urging her not to veto the sales legalization legislation even though her amendments were rejected. “Together, these bills address the real issues surrounding cannabis in the Commonwealth today: an already-existing, unregulated marijuana market operating openly across the state while consumers, communities, and law enforcement are left without the protections of a legal framework,” the groups wrote. “Let’s be clear: these bills do not create a marijuana market in Virginia. That market already exists,” the letter said. “What these bills do is replace today’s predatory and unaccountable illicit operators with a regulated marketplace, enforceable rules, oversight, product safeguards, age verification, and the strict consumer safety standards already in use for Virginia medical cannabis.” The letter was signed by Virginia NORML, Marijuana Justice, Virginia Cannabis Association, Marijuana Policy Project and other groups. Separately, a coalition of hemp businesses that joined with a major alcohol retailer in asking Spanberger to veto the marijuana bill before she did so said the move presents an “opportunity” to craft better cannabis policy. Meanwhile, the governor signed several other reform bills this session—including measures to protect the parental rights of marijuana consumers and allow patients to access medical cannabis in hospitals. Read the House budget legislation with cannabis provisions below: The post Virginia Lawmakers And Governor ‘Have A Deal’ On Bill To Legalize Marijuana Sales This Month appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

A Democratic congressman has filed a new bill that would drastically overhaul how drugs are classified under the Controlled Substances Act (CSA), including by letting states effectively force federal rescheduling by changing their own local laws. Under current law, federal officials conduct a multi-part analysis to determine which, if any of CSA’s five schedules to place drugs in—depending on factors such as their medical use, potential for abuse and safety or dependence liability. But advocates have complained that those criteria are ambiguous and that the Drug Enforcement Administration (DEA) often refuses to acknowledge widely accepted medical value of substances—pointing out that it has taken more than half a century to begin moving marijuana out of Schedule I, the most restrictive category—a process that is now underway due to a review initiated during the Biden administration and that is advancing under President Donald Trump. The new Controlled Substances Act Clarification in Sciences Act, filed this week by Rep. Steven Cohen (D-TN), would more clearly define in statute some of the criteria that officials with DEA and federal health agencies use to determine drugs’ scheduling status. A major change under the bill would define “accepted medical use” to include any use where “a jurisdiction has authorized the drug or substance for medical use,” “the drug or substance is widely used in such jurisdiction by health care practitioners” and “such legitimate medical use is recognized by the entities that regulate the practice of medicine in such jurisdiction through evidence-based scientific evaluation that employs rigorous and generally accepted methodologies.” Because drugs that have a currently accepted medical use cannot be classified under Schedule I, the reform contemplated by the bill would effectively mean that jurisdictions within the U.S., could force federal rescheduling of a drug by legalizing it for widespread medical use and having it recognized by local regulators. When the Department of Health and Human Services (HHS) conducted its analysis of marijuana rescheduling under the Biden administration, it attributed significant value to the fact that medical cannabis is so widely used under a growing number of state laws. Legalization opponents criticized that move and suggested it was an improper change in how scheduling status has historically been analyzed, but the new bill would effectively codify it. “Accuracy in federal drug policy will ensure both fairness and safety. Much has changed since 1970 when the Controlled Substances Act was enacted,” Cohen said in a press release. “My bill will clarify and update the CSA so that the evaluation of controlled substances is made on the best scientific evidence of today, not decades-old processes and outdated knowledge.” This week I introduced the Controlled Substances Act (CSA) Clarification in Sciences Act — legislation to ensure that decisions about controlled substances are based on today’s best scientific evidence, not outdated standards. For too long, the law has boxed promising treatments… pic.twitter.com/oYK7wmsGWz — Steve Cohen (@RepCohen) June 12, 2026 The legislation, H.R. 9186, would also define terms such as “physical dependence,” “potential for abuse,” “lack of accepted safety for use of the drug or other substance under medical supervision” and “potential benefits to society,” among others. It would additionally add a provision to the CSA clarifying that the attorney general must “defer to” the health and human services secretary’s “scientific and medical evaluation of a drug or other substance.” The official could “add or transfer a drug or other substance to a schedule only if such schedule best corresponds to controls reasonably tailored to protect public health and safety (including the potential for abuse and dependence liability of the drug or substance) while preserving access for accepted medical uses, and recognizing the potential benefits to society, of the drug or substance,” the bill says. A summary of the legislation from Cohen’s office says the bill will help address what it calls a “Schedule I ‘trap'” under which DEA has argued that drugs need Food and Drug Administration (FDA) approval in order to have a currently accepted medical use, but that Schedule I status has limited the very research that is needed to demonstrate such value. “This circular policy can trap substances in Schedule I, driving researchers from the field and reduce the number of FDA-approved medicines, especially those for mental health disorders,” it says. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Cohen said he “worked diligently with the nation’s leading scientific professional societies to ensure the bill’s approach reflects the gold standards in biomedical research and contemporary healthcare.” The legislation is endorsed by scientific societies such as the American College of Neuropsychopharmacology, American Society of Clinical Psychopharmacology, American Society for Pharmacology and Experimental Therapeutics and Society of Biological Psychiatry. “Therapeutic progress depends directly on the ability of physicians and researchers to study substances of interest,” the congressman said. “The current law’s imprecise approach to scheduling substances has created a system that is arbitrary and largely ignores the modern practice of medicine and public health, and has substantially hindered scientific progress.” Deanna Barch, president of the American College of Neuropsychopharmacology, said the measure “takes a long-needed step to enhance clarity and strengthen the scientific basis on which substances are reviewed for scheduling.” “By adding and updating critical definitions that the statute has lacked, it gives the administering agencies a sounder evidentiary foundation for their evaluations,” she said. “The scheduling framework these terms support has stood since the Controlled Substances Act was enacted in 1970, and bringing its core definitions into line with current science is an important and welcome advance.” Randy Hall, president of the American Society for Pharmacology and Experimental Therapeutics, added that the bill “addresses a barrier the research community has faced in studying controlled substances.” “In many cases, the constraints of scheduling status prevent scientists from understanding whether a substance may, in fact, have medical utility,” he said. “These updates will facilitate the investigation of the use of many substances in a variety of therapeutic areas.” Society of Biological Psychiatry President Dost Öngür noted that “for too long, the law has trapped promising treatments in a circular standard that blocks the very research needed to prove their value.” “By insisting that drug scheduling rest on evidence, this legislation reopens the door to discovery for the millions of Americans living with depression, PTSD, and other serious psychiatric conditions,” he said. Brooke Shockey Sanders, director of network relations for Students for Sensible Drug Policy (SSDP), said that “as a Neuroscience PhD researcher studying Schedule I drugs, the Controlled Substances Act (CSA) has shown to be the biggest barrier in my scientific advancement.” “Representative Cohen’s clarification of the CSA would allow for scientists, like myself, to conduct more cost effective, timely and accurate medical research of drugs currently confined by legal barriers,” she said. “This revision is promising for the future of medical advancement, allowing for development of novel therapeutic for diseases with large global prevalence rates.” The post New Bill In Congress Would Let States Force Federal Reclassification Of Drugs Like Marijuana And Psychedelics appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net